Vivo Capital as of March 31, 2017
Portfolio Holdings for Vivo Capital
Vivo Capital holds 23 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 25.1 | $85M | 2.9M | 29.82 | |
| Ascendis Pharma A S (ASND) | 14.6 | $50M | 1.8M | 28.00 | |
| Nabriva Therapeutics | 14.2 | $48M | 4.0M | 12.00 | |
| Codexis (CDXS) | 7.5 | $25M | 5.3M | 4.80 | |
| Eiger Biopharmaceuticals | 6.0 | $21M | 1.8M | 11.45 | |
| Advanced Accelerat spon ads each rep 2 ord | 5.7 | $19M | 484k | 39.86 | |
| Aimmune Therapeutics | 4.9 | $17M | 763k | 21.73 | |
| Strongbridge Bioph shs usd | 4.2 | $14M | 3.0M | 4.75 | |
| Capnia | 3.1 | $10M | 15M | 0.71 | |
| Biopharmx | 1.9 | $6.4M | 13M | 0.50 | |
| Trevena | 1.9 | $6.3M | 1.7M | 3.67 | |
| Akari Therapeutics | 1.7 | $5.8M | 528k | 11.07 | |
| Agile Therapeutics | 1.4 | $4.8M | 1.5M | 3.20 | |
| Aurinia Pharmaceuticals (AUPH) | 1.3 | $4.4M | 600k | 7.34 | |
| Foamix Pharmaceuticals | 1.2 | $4.2M | 855k | 4.95 | |
| Sierra Oncology | 1.1 | $3.7M | 2.4M | 1.53 | |
| Crispr Therapeutics (CRSP) | 0.9 | $3.2M | 149k | 21.77 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $3.2M | 164k | 19.30 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.3M | 300k | 7.81 | |
| Dynavax Technologies (DVAX) | 0.6 | $2.1M | 360k | 5.95 | |
| Sunesis Pharmaceuticals Inc Ne | 0.6 | $2.1M | 500k | 4.10 | |
| Revance Therapeutics | 0.5 | $1.6M | 77k | 20.80 | |
| Capnia Inc Common Stock Warrants | 0.0 | $113k | 944k | 0.12 |
